Regulating Efficacy and Wellness in Diabetes

Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01790724

Acronym

REWinD

Enrollment

125

Registered

2013-02-13

Start date

2013-01-31

Completion date

2014-05-31

Last updated

2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Type 2, Metabolic Syndrome

Brief summary

The propose of the study is to test the hypothesis that an eight week program consisting of walking exercise and social cognitive theory based group workshops will increase physical activity adherence six months later in older adults with type 2 diabetes or metabolic syndrome.

Interventions

BEHAVIORALWalking exercise

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

50 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* adults between the ages of 50-75 years * individuals diagnosed with type 2 diabetes or metabolic syndrome (presence of 3 of the 5 criteria) * physician consent to participate.

Exclusion criteria

* below age 50 or above age 75 at the beginning of the intervention * exercising regularly more than twice per week for the last six months * diagnosis of type 1 diabetes mellitus * failing the Telephone Interview of Cognitive Status * inability to communicate in English

Design outcomes

Primary

Measure	Time frame	Description
Physical Activity	Month 6	Change from baseline to month six in physical activity. Participants will wear an accelerometer to measure physical activity.

Secondary

Measure	Time frame	Description
Self-efficacy	Month 6	We will assess changes in self-efficacy by written questionnaires.
Executive function	Month 6	Participants will complete a neuropsychological battery of tasks assessing memory, attention and decision-making at baseline and month six.
Self-regulatory strategy use	Month 6	We will assess changes in self-regulatory strategy use by written questionnaires.
Physical function	Month 6	We will conduct functional fitness testing including tests of balance, strength, mobility and flexibility at baseline and six months.
Psychosocial outcomes	Month 6	We will assess changes in psychosocial function ( e.g. self-esteem; social support; anxiety) by written questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026